FREE
SHIPPING!

on all orders above $300.00

FREE Pills!

via4gra pills

for free with every order

OUR DRUG PRICES are

70%

Less than in your
local pharmacy

Search by letter:

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Hymox (Augmentin)
+ BONUS

Rating of sales:          

 
Hymox

Hymox is a penicillin antibiotic with a notably broad spectrum of activity. The bi-layer tablets provide an immediate release of amoxicillin and clavulanate potassium and an extended release of amoxicillin. This enhanced formulation prolongs the time that bacteria are exposed to the antibiotic and promotes coverage of tough-to-treat S. pneumoniae.

Other names for this medication:
Aclav, Alfoxil, Alphamox, Amimox, Amixen, Amobay, Amobiotic, Amocla, Amoclan, Amoclane, Amodex, Amoklavin, Amoksiklav, Amolin, Amorion, Amotaks, Amoval, Amoxal, Amoxan, Amoxibeta, Amoxicap, Amoxiclav, Amoxidal, Amoxidin, Amoxiduo, Amoxihexal, Amoxiplus, Amoxival, Amoxsan, Amoxy, Amoxydar, Ampliron, Amylin, Atoksilin, Augmaxcil, Augmentin, Augmex, Augpen, Bactoclav, Betamox, Bioclavid, Biomox, Blumox, Cavumox, Cilamox, Clabat, Clamentin, Clamicil, Clamovid, Clamoxin, Claneksi, Clavam, Clavamel, Clavamox, Clavaseptin, Clavet, Clavinex, Clavipen, Clavobay, Clavubactin, Clavucid, Clavulin, Clavulox, Clavumox, Clonamox, Curam, Dexyclav, Dimopen, Duomox, Enhancin, Exten, Fleming, Fulgram, Germentin, Gimaclav, Gloclav, Glomox, Grinsil, Hiconcil, Himox, Homer, Imadrax, Julmentin, Julphamox, Kesium, Klamoks, Klavox, Klavunat, Largopen, Macropen, Maxamox, Medoclav, Megamox, Megapen, Moxacil, Moxatag, Moxiclav, Moxilen, Moxilin, Moxypen, Myclav, Mymox, Natravox, Neomox, Nisamox, Noprilam, Noroclav, Novaclav, Novamox, Novax, Novocilin, Optamox, Oramox, Origin, Panklav, Pediamox, Pinamox, Ranclav, Ranmoxy, Ranoxyl, Rapiclav, Ronemox, Sulbacin, Suprapen, Synulox, Topcillin, Trifamox, Ultramox, Unimox, Vetrimoxin, Xiclav, Zoxil

Similar Products:
Amoxil, Cipro, Bactrim, Ampicillin, Trimox

 

Also known as:  Augmentin.

Description

Hymox is a brand name for an antibiotic, called co-amoxiclav, that is used to treat a wide range of conditions, from bronchitis to Lyme disease. It is one of the most commonly prescribed antibiotics for children, frequently dispensed for ear infections.

The drug is a combination of two active ingredients: amoxicillin and clavulanic acid. Together, the drugs fight bacteria that would ordinarily be resistant to amoxicillin alone.

Dosage

Hymox may be taken without regard to meals; however, absorption of clavulanate potassium is enhanced when Hymox is administered at the start of a meal. To minimize the potential for gastrointestinal intolerance, Hymox should be taken at the start of a meal.

The usual adult dose is one 500-mg tablet of Hymox every 12 hours or one 250-mg tablet of Hymox every 8 hours. For more severe infections and infections of the respiratory tract, the dose should be one 875-mg tablet of Hymox every 12 hours or one 500-mg tablet of Hymox every 8 hours. Adults who have difficulty swallowing may be given the 125 mg/5 mL or 250 mg/5 mL suspension in place of the 500-mg tablet. The 200 mg/5 mL suspension or the 400 mg/5 mL suspension may be used in place of the 875-mg tablet.

Two 250-mg tablets of Hymox should not be substituted for one 500-mg tablet of Hymox. Since both the 250-mg and 500-mg tablets of Hymox contain the same amount of clavulanic acid (125 mg, as the potassium salt), two 250-mg tablets are not equivalent to one 500-mg tablet of Hymox.

The 250-mg tablet of Hymox and the 250-mg chewable tablet should not be substituted for each other, as they are not interchangeable. The 250-mg tablet of Hymox and the 250-mg chewable tablet do not contain the same amount of clavulanic acid (as the potassium salt). The 250-mg tablet of Hymox contains 125 mg of clavulanic acid, whereas the 250-mg chewable tablet contains 62.5 mg of clavulanic acid.

Overdose

If you take too much this medication, call your healthcare provider or local Poison Control Center, or seek emergency medical attention right away.

If this medication is administered by a healthcare provider in a medical setting, it is unlikely that an overdose will occur. However, if overdose is suspected, seek emergency medical attention.

Storage

Store between 20 and 25 degrees C (68 and 77 degrees F) away from moisture and heat. Keep bottle closed tightly. Throw away any unused medicine after the expiration date. Keep out of the reach of children.

Side effects

The most common side effects associated with Hymox are:

  • hymox forte 250 mg
  • hymox capsule
  • hymox 500 mg amoxicillin
  • hymox antibiotic
  • hymox syrup
  • hymox tablet
  • hymox medicine
  • hymox forte 250 dosage
  • hymox tab
  • hymox 500mg dosage
  • hymox dosage
  • hymox 500 mg cap
  • hymox 875 mg

Side effect occurrence does not only depend on medication you are taking, but also on your overall health and other factors.

Contraindications

Serious and occasionally fatal hypersensitivity (anaphylactic) reactions have been reported in patients receiving beta-lactam antibacterials, including Hymox. These reactions are more likely to occur in individuals with a history of penicillin hypersensitivity and/or a history of sensitivity to multiple allergens. Before initiating therapy with Hymox, careful inquiry should be made regarding previous hypersensitivity reactions to penicillins, cephalosporins, or other allergens. If an allergic reaction occurs, Hymox should be discontinued and appropriate therapy instituted.

hymox 500 mg amoxicillin

A negative endoscopy result was demonstrated in 15 children after treatment. Symptoms and respiratory function significantly improved after treatment and 1 month later; 8 children had intermittent asthma and 10 had mild asthma. A significant reduction of inflammatory cell numbers was detected in all asthmatic children. Interleukin 4 levels significantly decreased (P < 0.001), whereas interferon-y levels increased (P < 0.001).

hymox 500mg dosage

Nineteen beta-lactamase-negative ampicillin-resistant (BLNAR) and 2 beta-lactamase-positive amoxicillin-clavulanic acid-resistant Canadian Haemophilus influenzae strains were characterized. All 21 isolates were found to have the N526K mutations in their ftsI genes, and their ampicillin MIC(50) values were 4-8 times that of beta-lactamase-negative ampicillin-susceptible strains. The difficulty in detection of BLNAR strains was discussed.

hymox forte 250 mg

The effectiveness of amoxicillin/clavulanic acid (A/Cl) and trimetoprim (TMP) were compared in two different schedules: 10 days treatment and monodose, in 80 patients with, urinary tract infection (UTI) demonstrated by urine culture. The patients over 65 years, the males and those with underlying risk conditions randomly received A/Cl or TMP during 10 days. The rates of cure were 76.9% for A/Cl and 73.9% for TMP. The difference was not significant. Thirty-one patients without those features randomly received a short A/Cl course or a single dose of TMP. The rates of cure were 92.8% for A/Cl and 58.8% for TMP. The difference was statistically significant. It was concluded that, in our patients, complicated lower UTI have a similar response rate to a ten days course of A/Cl or TMP, whereas A/Cl for three days is more effective than a single TMP dose to treat noncomplicated lower UTI.

hymox tablet

A single-center, prospective, randomized, double-blind, controlled clinical trial was designed. The study population consisted of 100 patients who underwent impacted TM extractions. Patients were distributed into 2 groups of 50 individuals each. Postoperatively, one group was administered MXF (400 mg/24 hours for 5 days); the positive control group received amoxicillin and clavulanic acid (AMX-CLV) (500/125 mg/8 hours for 5 days). Follow-up was performed for 7 postoperative days, during which the patient recorded information on pain, the use of rescue analgesia, undesirable effects of the medication, difficulty in speaking, difficulty in chewing, diet consistency, difficulty performing oral hygiene, asthenia, time in bed, going out of the house, and returning to work.

hymox 500 mg cap

A specimen of the appendice and the peritoneal exudates (if exists) was performed intraoperatively for aerobe bacteriological examination. Anaerobic incubation was not possible in our study.

hymox medicine

The data support the use of doxycycline or co-amoxiclav as appropriate empiric treatment for LRT infection caused by the pathogens investigated, for patients in primary care.

hymox forte 250 dosage

We describe 2 new cases which followed a favorable course. This is the usual outcome although inflammatory manifestations may persist or relapse.

hymox 875 mg

The MICs of amoxicillin, mezlocillin and BRL 25,000, a combination of two parts amoxicillin and one part clavulanic acid (2AM + 1CA), were measured for 331 Enterobacteriaceae strains which produced beta-lactamases as demonstrated by nitrocefin. The MIC values for mezlocillin and the combination 2AM + 1CA were very similar for the total number of the strains investigated. When investigated separately according to the bacterial species, three different sensitivity groups were established for the above-mentioned preparations: 1) species with the same or similar sensitivity to mezlocillin and 2AM + 1CA (Escherichia coli and Shigella spp., amoxicillin-resistant strains); 2) species which were more sensitive to mezlocillin than to the combination 2AM + 1CA (Citrobacter spp., Enterobacter cloacae, Serratia spp. and indole-positive Proteus as well as strains of E. coli and Shigella spp. which produce a cephalosporinase and are sensitive to amoxicillin); 3) species which are more sensitive to 2AM + 1CA than to mezlocillin (amoxicillin-resistant Salmonella spp., Proteus mirabilis and Klebsiella pneumoniae). This complementary activity of mezlocillin and 2AM + 1CA against Enterobacteriaceae depended on the beta-lactamases produced.

hymox syrup

The efficacy and safety of intravenous and sequential intravenous-oral clavulanate-potentiated amoxycillin therapy was evaluated in 71 hospitalized paediatric patients, one month to 16 years of age. The infections treated included peritonsillar abscess (2 patients), purulent tracheitis (1), acute epiglottitis (24), pneumonia (31), pansinusitis (4), mastoiditis (1), cellulitis (4), lymphadenitis (2) and pyelonephritis (2). The severity of disease was rated as moderate in 31 patients (44%), and as severe in 40 (56%). Bacterial pathogens could be cultured in 26 cases (37%). The response to therapy was prompt and followed by clinical cure in each patient. Adverse drug effects included phlebitis (in 6%), mild gastrointestinal complaints (6%), rash (4%) and transient neutropenia and elevation of transaminases (one case each). It is concluded that amoxycillin/clavulanate is effective and safe treatment for bacterial infections of the respiratory tract, urinary tract, skin or soft tissues in children.

Target Point Shipping Method Tracking Delivery Time Price
Worldwide shipping

Worldwide shipping

Registered Mail  Not trackable 14-21 business days USD 20.00 per order
EMS  Trackable, where available 5-9 business days USD 30.00 per order

Delivery time is:

Registered Mail - 14-21 business days, prices - USD 20.00, no signature is required on delivery.
EMS - 5-9 business days, prices - USD 30.00, signature is required on delivery.
Your order will be packed safe and secure and dispatched within 24 hours.

front back side

This is exactly how your parcel will look like (pictures of a real shipping item). It has a look of a regular private letter and does not disclose its contents. Size - 9.4x4.3x0.3 inches (24x11x0.7cm).

Testimonials
Best
 Show Hide 
hymox medicine 2017-07-08

Treatment with oral antibiotics is as effective as parenteral then oral treatment in the management Tetramin Holiday Review of the first episode of clinical pyelonephritis in children.

hymox dosage 2015-01-25

Hundred and thirty-seven consecutive FN were recorded in 128 patients. Twenty-six FN ( Omnicef Dosing Chart 19%) were managed at home (all of them had a MASCC score ≥ 21); 111 (81%) were treated at hospital of which 37 NF were at HR of complications based on clinical and biological parameters (all of them had a MASCC score < 21) and for 74 of them the admission could be discussed (MASCC < 20 or ≥ 20). This group of patients was considerate with intermediate risk (IR). All IR patients were treated with the same antibiotics than outpatients, i.e. ceftriaxone in 36 cases (49%) or amoxicillin/clavulanic acid and ciprofloxacin in 38 cases (51%). For these 74 cases, any severe complication was recorded. Antibiotics were adapted for only 12% of these patients according to bacteriology results.

hymox 500mg dosage 2016-11-16

Цель работы. Определить актуальность инфекций области хирургического вмешательства (ИОХВ) после аппендэктомии с лапаротомным доступом по Волковичу—Дьяконову на современном этапе и оценить эффективность комплексного подхода к профилактике их развития. Материал и методы. Проведено многоцентровое проспективное рандомизированное слепое исследование в трех хирургических отделениях (центрах) стационаров Смоленска, в которых в наблюдение были включены первые 50 пациентов, госпитализированных последовательно с 01.01.12 по 30.11.12 (I период). Истории болезни (ИБ) пациентов были запрошены в архиве и подвергнуты ретроспективной оценке одним экспертом. Для проспективной оценки эффективности комплексного подхода к профилактике ИОХВ в наблюдение были включены пациенты, последовательно поступавшие с 01.12.12 (II период) в те же хирургические отделения. В каждом центре были включены по 66 пациентов, которые предварительно были рандомизированы на равные группы по 33 человека. Всем пациентам планировалось проведение профилактики ИОХВ амоксициллином/клавуланатом, т.е. «стандартизированной» антибактериальной профилактики (АБП), под которой понимали ограничение выбора антибиотика при хирургических вмешательствах одного вида в обычных условиях одним препаратом в отличие от «рутинной» практики АБП без какой-либо регламентации (на усмотрение врача). Анализируемую (1-ю) группу с комплексным подходом к профилактике ИОХВ составили пациенты, которым операционная рана была ушита шовным материалом полиглактином 910, импрегнированным триклозаном и дополнительно закрыта кожным клеем на основе 2-октилцианоакрилата, а контрольную (2-ю) — без триклозана. В наблюдение были включены 198 пациентов (по 99 в каждой группе). Для каждого пациента были приготовлены «индивидуальные пакеты профилактики ИОХВ», включавшие помимо антибиотика, шовного материала и клея (последний — только в пакетах для комплексной профилактики) еще и «стикер АБП» — наклейку в ИБ о факте проведения процедуры. ИБ пациентов II периода были подвергнуты анализу одним экспертом. При указании в ИБ контактных телефонов пациентов обоих периодов была предпринята попытка их телефонного опроса в целях установления факта развития/отсутствия Enhancin Bd Syrup ИОХВ после выписки в сроки до 30 дней с момента оперативного вмешательства. Критериями исключения из окончательного анализа являлись следующие условия: возраст менее 14 лет, конверсия (переход на срединную лапаротомию); выполнение дренирования брюшной полости через операционную рану; симультанные вмешательства; вторичный аппендицит; полный отказ от использования шовного материала из индивидуального пакета профилактики ИОХВ». Все полученные в результате исследования сведения были внесены в индивидуальные регистрационные карты (ИРК) с последующим переносом информации в единую электронную базу данных методом двойного ввода. Результаты. В окончательный анализ были включены 322 пациента — 158 (49,0%) женщин и 164 (50,9%) мужчины, средний возраст которых составил 34,8±17,1 года. Средняя длительность госпитализации составила 8,2±2,5 сут. Длительность госпитализации пациентов без и с ИОХВ составила в среднем 7,9±1,8 и 14,2±4,0 сут соответственно (р<0,001). Частота проведения АБП в I и II периодах исследования составила 56,1% (83/148) и 97,7% (170/174) соответственно (р<0,00001). В ИБ 98,9% (90/91) пациентов 1-й группы II периода и 92,8% (77/83) пациентов 2-й группы II периода присутствовал стикер АБП о проведении процедуры. Наиболее часто для профилактики ИОХВ в I периоде использовались цефалоспорины I—IV поколений, общая доля которых составила 85,6% (83/97). Во II периоде исследования в 98,2% (167/170) случаев использовали амоксициллин/клавуланат из индивидуального пакета профилактики ИОХВ. Почти половину всех случаев в I периоде составили случаи в/м введения антибиотика, в/в введение отмечено в 57,3% (55/96). Во II периоде подавляющее большинство случаев было представлено в/в введением препарата — 98,2% (167/170), р<0,0001. В I и II периодах первое введение препарата до разреза (пред­операционная АБП) отмечено у 53,6% (44/82) и 97,1% (165/170) пациентов соответственно (р<0,0001). За оба временных периода исследования ИОХВ в ИБ документирована у 3,7% (12/322) пациентов и недокументирована, по мнению эксперта, еще у 2,5% (8/322) пациентов. Таким образом, частота развития «суммарной ИОХВ» на госпитальном этапе составила 6,2% (20/322). Доля пациентов, с которыми был осуществлен телефонный контакт в оба периода исследования, составила 74,8% (241/322), 56,8% (84/148) и 90,2% (157/174) соответственно. Частота «заявленной ИОХВ», развившейся на госпитальном этапе и после выписки у пациентов в I и II периодах составила 10,1% (15/148) и 12,1% (21/174) соответственно (р>0,05). Абсолютное большинство пациентов 86,1% (31/36) с «заявленной ИОХВ» обращались по этому поводу за медицинской помощью после выписки из стационара. Регистрация «общей ИОХВ» происходило только один раз для одного пациента со следующим приоритетом: ИОХВ диагностирована и документирована на госпитальном этапе, ИОХВ не документирована, заявленная ИОХВ. Таким образом, частота развития общей ИОХВ у всех пациентов в оба временных периода исследования, I и II периодах составила 14,9% (48/322), 15,5% (23/148) и 14,4% (25/174) соответственно. Частота развития общей ИОХВ в 1-й и 2-й группах II периода составила 11,0% (10/91) и 18,1% (15/83) соответственно. Различия не являлись статистически значимыми для всех пар сравнений (р>0,05). При оценке субпопуляции пациентов, с которыми был осуществлен телефонный контакт, частота общей ИОХВ в оба временных периода исследования, I и II периодах 17,4% (42/241), 21,4% (18/84) и 15,3% (24/157) соответственно. Частота развития общей ИОХВ в 1-й и 2-й группах II периода в субпопуляции составила 12,0% (10/83) и 18,9% (14/74) соответственно, р>0,05 для всех пар сравнения. Выводы. ИОХВ после традиционной аппендэктомии остаются актуальной проблемой современной хирургии. Для определения истинной частоты развития ИОХВ необходимо совершенствовать национальную систему регистрации нозокомиальных инфекций. Комплексный подход к профилактике ИОХВ с использованием «индивидуального пакета профилактики ИОХВ» продемонстрировал тенденцию к значительному снижению риска развития таких осложнений в сравнении со стандартизированной АБП и рутинной практикой АБП, что позволяет рекомендовать его для максимального повышения противоинфекционной защиты пациентов. Для достоверного подтверждения этого факта необходимы дальнейшие, более масштабные исследования.

hymox capsule 2017-01-07

A satisfactory clinical outcome (cure or improvement of symptoms) was found in 86% (49/ Karin Slaughter Blindsighted Read Online 57) and 71.4% (30/42) of the clinically evaluable patients treated with cefuroxime or co-amoxiclav, respectively (p >0.05).

hymox antibiotic 2016-02-29

The attainable inhibitory ratios (AR) for oral antibiotics were calculated by using literature reports of concentrations attained in respiratory secretions for amoxicillin-clavulanic acid (AMX/CA), ofloxacin (OFL), L-ofloxacin (L-OFL), cefuroxime (CEFU), ciprofloxacin (CIP), and enoxacin (ENO), and using microdilution minimum inhibitory concentration data of these antimicrobials against the common bacterial respiratory pathogens. AR of each antibiotic against the pathogens was expressed as multiples of the MICs achieved at the respiratory site. Bacteria tested included Staphylococcus aureus, group-A and group-B streptococci, Viridans streptococci, Streptococcus pneumoniae, Brahamella catarrhalis, Klebsiella pneumoniae, Eikenella corrodens, Haemophilus influenzae, H. parainfluenzae, Pseudomonas aeruginosa, and Legionella pneumophila. The antimicrobials with the narrowest spectrum of activity were amoxicillin-clavulanic acid and cefuroxime which had high attainable inhibitory ratios only against Gram-positive cocci. Ofloxacin and L-oflaxacin were among the quinolones with the highest overall ARs against respiratory pathogen Clarimax 125 Mg 5 Ml , including, L. pneumophila, H. influenzae, and B. catarrhalis. All agents showed no, or inadequately low ARs for P. aeruginosa.

hymox syrup 2017-01-29

Human bite on genitalia is a rare cause of penile ulceration, but is increasingly being reported, probably due to the increasing frequency of orogenital sex. The great morbidity associated with it brings it under the category of high-risk bite wounds, similar to those on hands, feet and joints. We report a case and review the literature on human Ronemox 500 Medicine bite-induced penile ulceration.

hymox forte 250 mg 2015-03-23

A previously healthy, 52-year-old man was presented to our outpatient clinic with a complaint of acute, atraumatic onset of severe back pain for more than 1 month. Initially, he was misdiagnosed at another clinic as myofascial pain and treated with nonsteroidal anti-inflammatories and physical therapy, which he did not benefit from. He never complained of fever; however, laboratory tests revealed raised erythrocyte sedimentation values, increased C-reactive protein values but normal leukocyte count. Thoracal and lumbal plain radiographs were nonspecific. Magnetic resonance imaging demonstrated increased signal intensity in vertebral bodies and intervertebral disc space through T12-L4 and in the paravertebral musculature at L2-L3 with contrast enhancement. Blood cultures and Chloromycetin Antibiotic Uses computed tomography-guided needle biopsy and cultures were negative.

hymox forte 250 dosage 2015-02-09

Our findings indicate that amoxicillin Purbac Ds 960 Mg Tablets /clavulanate has superior bacteriologic and clinical efficacy compared with azithromycin in children with AOM.